Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association
Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable
increase in the risk for this disease after menopause and typically develop coronary heart …
increase in the risk for this disease after menopause and typically develop coronary heart …
Pregnancy and reproductive risk factors for cardiovascular disease in women
Beyond conventional risk factors for cardiovascular disease, women face an additional
burden of sex-specific risk factors. Key stages of a woman's reproductive history may …
burden of sex-specific risk factors. Key stages of a woman's reproductive history may …
[HTML][HTML] The clinician's guide to prevention and treatment of osteoporosis
MS LeBoff, SL Greenspan, KL Insogna… - Osteoporosis …, 2022 - Springer
Osteoporosis is the most common metabolic bone disease in the USA and the world. It is a
subclinical condition until complicated by fracture (s). These fractures place an enormous …
subclinical condition until complicated by fracture (s). These fractures place an enormous …
Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …
Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …
Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …
[HTML][HTML] Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence
Collaborative Group on Hormonal Factors in Breast … - The Lancet, 2019 - Elsevier
Background Published findings on breast cancer risk associated with different types of
menopausal hormone therapy (MHT) are inconsistent, with limited information on long-term …
menopausal hormone therapy (MHT) are inconsistent, with limited information on long-term …
Treating menopause—MHT and beyond
Every woman who lives past midlife will experience menopause, which, by definition, is
complete cessation of ovarian function. This process might occur spontaneously (natural …
complete cessation of ovarian function. This process might occur spontaneously (natural …
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes
Stroke has multiple etiologies, but the underlying genes and pathways are largely unknown.
We conducted a multiancestry genome-wide-association meta-analysis in 521,612 …
We conducted a multiancestry genome-wide-association meta-analysis in 521,612 …
Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical …
Importance The influence of menopausal hormone therapy on breast cancer remains
unsettled with discordant findings from observational studies and randomized clinical trials …
unsettled with discordant findings from observational studies and randomized clinical trials …
Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline
Abstract Objective To update the “Endocrine Treatment of Transsexual Persons: An
Endocrine Society Clinical Practice Guideline,” published by the Endocrine Society in 2009 …
Endocrine Society Clinical Practice Guideline,” published by the Endocrine Society in 2009 …